Cargando…

Immunosuppressive therapy in dermatology and PML

Detalles Bibliográficos
Autores principales:	Sterry, Wolfram, Bagot, Martine, Ferrandiz, Carlos, Kragballe, Knud, Papp, Kim, Stingl, Georg
Formato:	Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2009
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2701562/ https://www.ncbi.nlm.nih.gov/pubmed/19138293 http://dx.doi.org/10.1111/j.1610-0387.2008.06993.x

Ejemplares similares

Training Physician‒Scientists in Dermatology in Austria
por: Stingl, Georg
Publicado: (2021)

Pembrolizumab as a treatment for PML?: Waiting for Godot
por: Du Pasquier, Renaud A.
Publicado: (2019)

PML Degradation: Multiple Ways to Eliminate PML
por: Rabellino, Andrea, et al.
Publicado: (2013)

The limited contribution of DNA methylation to PML-RARα induced leukemia
por: Rohde, Christian, et al.
Publicado: (2013)

Targeting TRIB3 and PML-RARα interaction against APL
por: Li, Ke, et al.
Publicado: (2017)

Immunosuppressive and immunomodulatory therapies in dermatology and coronavirus disease 2019 (COVID-19)
por: Mansouri, Parvin, et al.
Publicado: (2021)

Novel function of the tumor suppressor PML at ER-mitochondria sites in the control of autophagy
por: Missiroli, Sonia, et al.
Publicado: (2017)

COVID-19 and immunomodulator/immunosuppressant use in dermatology
por: Price, Kyla N., et al.
Publicado: (2020)

Dermatology
Publicado: (1894)

Restoring PML tumor suppression to combat cancer
por: Wolyniec, Kamil, et al.
Publicado: (2012)

Regulation of NF-κB by PML and PML-RARα
por: Ahmed, Abrar, et al.
Publicado: (2017)

PML and PML-like exonucleases restrict retrotransposons in jawed vertebrates
por: Mathavarajah, Sabateeshan, et al.
Publicado: (2023)

Recommendations for COVID Vaccination for Dermatological Patients on Immunosuppressive/Immunomodulatory Therapy (IADVL Academy)
por: Munisamy, Malathi, et al.
Publicado: (2021)

Maraviroc in PML-IRIS: A separate ball game under HIV infection and natalizumab?
por: Steiner, Israel, et al.
Publicado: (2017)

The PML hub: An emerging actor of leukemia therapies
por: Rérolle, Domitille, et al.
Publicado: (2023)

Thanksgiving
por: Sterry, Ruth
Publicado: (1914)

Tropical Dermatology
Publicado: (1927)

Allyship in dermatology
por: Feaster, Brittany, et al.
Publicado: (2021)

Dermatology in India and Indian dermatology: A Medico-Historical perspective
por: Mukhopadhyay, Amiya K.
Publicado: (2016)

A link between long-term natalizumab dosing in MS and PML: Putting the puzzle together
por: Major, Eugene O., et al.
Publicado: (2016)

Vaccine considerations for adult dermatology patients on immunosuppressive and immunomodulatory therapies: a clinical review
por: Tan, Alice J, et al.
Publicado: (2021)

Embracing diversity in dermatology: Creation of a culture of equity and inclusion in dermatology
por: Desai, Seemal R., et al.
Publicado: (2021)

Turning the Tide: How the Women’s Dermatologic Society Leads in Diversifying Dermatology
por: Sekyere, Nana Amma N., et al.
Publicado: (2020)

PML goes to the centrosome
por: Wells, William A.
Publicado: (2005)

PML, SUMOylation, and Senescence
por: Ivanschitz, Lisa, et al.
Publicado: (2013)

PML Bodies in Mitosis
por: Lång, Anna, et al.
Publicado: (2019)

Circadian behavior of mice deficient in PER1/PML or PER2/PML
por: Miki, Takao, et al.
Publicado: (2013)

COVID-19 and Dermatology
por: Das, Anupam
Publicado: (2021)

Viral Diseases in Dermatology
por: Goldust, Mohamad
Publicado: (2023)

Changes in the Brazilian Annals of Dermatology. Unpostponable initiatives
por: Talhari, Sinésio, et al.
Publicado: (2019)

Impact of the COVID-19 Pandemic on Immunomodulatory and Immunosuppressive Therapies in Dermatology: Patient and Physician Attitudes in Argentina()
por: Zimman, S., et al.
Publicado: (2020)

Expression and Function of PML-RARA in the Hematopoietic Progenitor Cells of Ctsg-PML-RARA Mice
por: Wartman, Lukas D., et al.
Publicado: (2012)

PML isoforms in response to arsenic: high-resolution analysis of PML body structure and degradation
por: Hands, Katherine J., et al.
Publicado: (2014)

Severe early natalizumab-associated PML in MS: Effective control of PML-IRIS with maraviroc
por: Bsteh, Gabriel, et al.
Publicado: (2017)

The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA
por: Jaffray, Ellis G., et al.
Publicado: (2023)

Introduction to women's health therapeutics in dermatology: Special edition of the International Journal of Women's Dermatology
por: Murase, J.E.
Publicado: (2017)

Introduction to Dermatology in Primary Care
por: Keir, Jeffrey
Publicado: (2011)

History of Women in Dermatology series
por: Grant-Kels, Jane, et al.
Publicado: (2015)

Dermatologic care of the transgender patient()()
por: Ginsberg, B.A.
Publicado: (2016)

The Impact of Novel Coronavirus on Dermatology
por: Piccolo, Vincenzo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_s9k9nskr5fgb2atrecrgokmisp